Send this to a friend

MedAware raises $8M toward ending prescription errors

MedAware, which uses algorithms to detect and eliminate prescription errors, said the company has raised $8 million in Series A funding.

MedAware, an Israeli company with North American headquarters in Stamford, intends to use the funding, in part, to develop additional machine learning-enabled decision support solutions and make ongoing product improvements to cover more catastrophic types of errors. Other 2017 priorities include further establishing its North American fo ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

ADVERTISEMENTS
Copyright 2017 New England Business Media